Childhood dementia | |
---|---|
Other names | Pediatric dementia |
Specialty | Neurology, Psychiatry, Pediatrics |
Symptoms | Loss of previously acquired developmental skills, seizures, cognitive decline |
Usual onset | Childhood or adolescence |
Duration | Progressive |
Causes | Genetic disorders, neurodegenerative diseases |
Diagnostic method | Biochemical testing, genetic testing |
Treatment | Most constituent disorders are untreatable and patients receive symptom management (medication, ) |
Prognosis | Severely reduced life expectancy as a whole. Median life expectancy of 9 years |
Childhood dementia is an umbrella group of rare, mostly untreatable neurodegenerative disorders that show symptoms before the age of 18. These conditions cause progressive deterioration of the brain and the loss of previously acquired skills such as talking, walking, and playing.
Other symptoms and complications are the loss of movement, vision, and hearing; seizures; and cardiorrespiratory, bone, and joint problems. As the conditions progress, so does their impact on life expectancy, quality of life. Due to this, most conditions in the group have a poor prognosis and cause a high degree of dependence as they progress.
Childhood dementia is genetic and progressive, distinguishing it from other sources of cognitive decline like traumatic brain injury and nutrient deficiencies.
Classification and terminology
Childhood dementias are a heterogenous group of genetic neurodegenerative disorders, that present symptoms before the age of 18. They are typically monogenic (caused by mutations of a single gene).
Their main characteristics are chronic and widespread cognitive decline; loss of previously acquired developmental skills after a period of development; and behaviours and psychological symptoms of dementia (BPSD).
Childhood dementias are distinct from sources of intellectual disability in childhood that are non-progressive (e.g traumatic brain injury) or acquired (e.g nutritional deficiencies or encephalitis).
Prognosis
The prognosis for childhood dementia is generally poor, with most children experiencing a significant decline in cognitive and motor function.
The impact on life expectancy depends on the individual condition, but is usually severe without treatment. It's estimated only 25–29% of people affected survive to adulthood, and only 10% to the age of 50. The median life expectancy is around 9 years, and the average life expectancy is 16.3 years.
The causes of death are attributed to respiratory complications in the late stage of the disease (e.g. pneumonia), neurological complications (e.g. drug resistant epilepsy), and cardiac events.
Signs and symptoms
By their usual definitions, childhood dementias always cause global neurocognitive decline. In some childhood dementia conditions the child's early development is indistinguishable from their healthy peers, then slows or plateaus before declining. In other childhood dementia disorders, early development may be slower than typical before declining.
This progressive decline causes difficulty concentrating, memory loss, confusion, and learning difficulties, in addition to the loss of developmental skills acquired previously, such as: walking, talking, writing, reading, and playing. Eventually the body loses its ability to function, leading to an early death.
Other symptoms and complications can occur depending on the subtype.
Other symptoms:
- Behavioral changes: Changes in one's personality, aggression, and hyperactivity.
- Motor decline: Loss of coordination, balance, and movement abilities.
- Seizures: Frequent in many forms of childhood dementia.
Other complications:
- Loss of vision or hearing.
- Cardiovascular, respiratory, and/or digestive problems
- Bone or joint problems.
Causes
The majority of childhood dementia cases are caused by genetic diseases. More than 145 monogenic diseases have been identified that cause dementia with onset in childhood. Examples include lysosomal disorders such as Sanfilippo syndrome, Niemann-Pick disease type C and Neuronal Ceroid Lipofuscinoses (NCLs or Batten Disease), some mitochondrial diseases such as Leigh syndrome and peroxisomal disorders such as X-linked adrenoleukodystrophy. Two-thirds of the cases can be attributed to inborn errors of metabolism.
Diagnosis
Diagnosis typically involves a combination of biochemical testing and genetic testing, often performed around the age of four. Early diagnosis is crucial for managing symptoms and improving the quality of life for those affected. In most cases, childhood dementia is diagnosed after developmental regression is observed.
Challenges in diagnosis
Childhood dementia is very often diagnosed late, misdiagnosed, or not diagnosed at all. A correct diagnosis happens, on average, 2 years or more after symptoms become apparent. Additionally, children affected by childhood dementia are often misdiagnosed with:
- Autism
- Developmental or intellectual delay
- ADHD
- Others
These issues in diagnosis are attributed to the:
- rarity of individual childhood dementia disorders
- initial presenting symptoms not being specific to childhood dementia
- long wait times to access specialists
- limited access to genomic testing
- lack of longitudinal or observational data
- lack of awareness
- lack of clear pathways for diagnosis and referrals
Management
Treatment of childhood dementia focuses on managing symptoms and improving quality of life.
This can include:
- Medications: Anti-seizure medications, behaviour-modifying drugs, and muscle relaxants.
- Therapies: Physiotherapy, occupational therapy, and speech therapy are used to maintain physical function for as long as possible.
- Supportive care: This includes comprehensive care to address complications related to mobility, feeding, breathing, and communication. Supportive care measures are customized for each patient and may include:
- Nutritional support, including the use of feeding tubes when swallowing becomes difficult.
- Palliative care to ensure comfort and quality of life as the disease progresses.
Psychological impact
Childhood dementia can significantly affect both parents and the affected child by causing anxiety, feelings of helplessness, profound grief, and a sense of loss as the child conditions continues to progress over time. Children with childhood dementias suffer severe sleep disturbances, movement disorders (e.g. muscle spasms, tremors), deterioration of communication skills, loss of vision and hearing, mood disorders, psychosis (including hallucinations and delusions) and incontinence. This situation can cause many emotional changes for parents and children. The psychological impacts that it has on children are confusion/frustration, loss of independence, social isolation, and fear, while parents often experience self-blame, stress, financial problems, and a loss of identity. For example, sleep disturbances and behavioral difficulties can exacerbate parent distress, anxiety, sleep quality and subsequent capacity to care for their child healthcare needs.
Epidemiology
Current estimates place the incidence of childhood dementias at 1 in 1186 births. This is higher than the incidence of some diseases with more widespread awareness, such as cystic fibrosis (affecting around 1 in 3000-4000 births) and spinal muscular atrophy (around 1 in 11000 births).
Meanwhile, the estimates for the prevalence are lower, at 1 in 3484 people in the general population and 1 in 1715 among children.
History
The concept of childhood dementia gained recognition in the early 20th century with the identification of Batten disease, one of the first known forms of childhood dementia, by British neurologist Frederick Batten in 1903.
Society and culture
Awareness
Despite its significance, childhood dementia has a very limited amount of awareness in popular culture, the medical community, and the media. Most health professionals have limited understanding and experience with individual childhood dementia conditions.
See also
References
- ^ Elvidge, Kristina L; Christodoulou, John; Farrar, Michelle A (2023-07-20). "Collective burden of childhood dementia: a scoping review". Brain. 146 (11): 4446–4464. doi:10.1093/brain/awad208. PMC 10545495. PMID 37365902. Retrieved 2024-09-24.
- ^ Djafar, Jason V.; Johnson, Alexandra M.; Elvidge, Kristina L.; Farrar, Michelle A. (2023-02-01). "Childhood Dementia: A Collective Clinical Approach to Advance Therapeutic Development and Care". Pediatric Neurology. 139: 76–85. doi:10.1016/j.pediatrneurol.2022.11.015. ISSN 0887-8994. PMID 36571866.
- ^ Nevin, Suzanne M.; McGill, Brittany C.; Kelada, Lauren; et al. (2023-09-07). "The psychosocial impact of childhood dementia on children and their parents: a systematic review". Orphanet Journal of Rare Diseases. 18 (1): 277. doi:10.1186/s13023-023-02859-3. ISSN 1750-1172. PMC 10486052. PMID 37679855.
- ^ "Childhood Dementia". Dementia Australia. Retrieved 2024-09-24.
- ^ Hemsley, Kim; Smith, Nicholas; Mubarokah, Siti (2024-04-26). "What is childhood dementia? And how could new research help?". The Conversation. Retrieved 2024-09-24.
- ^ Schulz, Angela; Kohlschütter, Alfried (2013). "NCL Disorders: Frequent Causes of Childhood Dementia". Iranian Journal of Child Neurology. 7 (1): 1–8. PMC 3943077. PMID 24665282.
- ^ Nunn, K; Williams, K; Ouvrier, R (April 2002). "The Australian Childhood Dementia Study". European Child & Adolescent Psychiatry. 11 (2): 63–70. doi:10.1007/s007870200012. PMID 12033746.
- ^ Atee, Mustafa; Whiteman, Ineka; Lloyd, Rebecca; Morris, Thomas (2024). "Behaviours and psychological symptoms of childhood dementia: two cases of psychosocial interventions". Palliative Care and Social Practice. 18: 26323524241273492. doi:10.1177/26323524241273492. ISSN 2632-3524. PMC 11378187. PMID 39247715.
- ^ "Childhood dementia initiative - supporting document 2 - 2021-22 Pre-Budget Submissions" (PDF).
- Nevin, Suzanne M.; McGill, Brittany C.; Kelada, Lauren; et al. (2023-09-07). "The psychosocial impact of childhood dementia on children and their parents: a systematic review". Orphanet Journal of Rare Diseases. 18 (1): 277. doi:10.1186/s13023-023-02859-3. ISSN 1750-1172. PMC 10486052. PMID 37679855.
- "Childhood dementia initiative - supporting document 2 - 2021-22 Pre-Budget Submissions" (PDF).
- ^ "Childhood dementia". DZNE Abt fuer Presse-und Oeffentlichkeitsarbeit (in German). Retrieved 2024-10-01.
- ^ "What is childhood dementia?". Childhood Dementia Initiative. Retrieved 2024-10-01.
- "What is Childhood Dementia? - Causes & Symptoms". 2022-09-07. Retrieved 2024-10-15.
- Warmerdam, HAG; Termeulen-Ferreira, EA; Tseng, LA; Lee, JY; van Eeghen, AM; Ferreira, CR; van Karnebeek, CDM (2019). "A Scoping Review of Inborn Errors of Metabolism Causing Progressive Intellectual and Neurologic Deterioration (PIND)". Frontiers in Neurology. 10: 1369. doi:10.3389/fneur.2019.01369. PMC 7040240. PMID 32132962.
- ^ Nevin, Suzanne M.; McGill, Brittany C.; Kelada, Lauren; et al. (2023-09-07). "The psychosocial impact of childhood dementia on children and their parents: a systematic review". Orphanet Journal of Rare Diseases. 18 (1): 277. doi:10.1186/s13023-023-02859-3. ISSN 1750-1172. PMC 10486052. PMID 37679855.
- ^ "2f9e6e3e0c96123950b620303dd1a6c6.pdf" (PDF).
- ^ "Childhood dementia initiative - supporting document 1 - 2021-22 Pre-Budget Submissions" (PDF).
- ^ Elvidge, Kristina L; Christodoulou, John; Farrar, Michelle A (2023-07-20). "Collective burden of childhood dementia: a scoping review". Brain. 146 (11): 4446–4464. doi:10.1093/brain/awad208. PMC 10545495. PMID 37365902. Retrieved 2024-09-24.
- "Childhood Dementia Support". Dementia Support Australia. Retrieved 2024-09-24.
- Sanders, Don B.; Fink, Aliza (August 2016). "Background and Epidemiology". Pediatric Clinics of North America. 63 (4): 567–584. doi:10.1016/j.pcl.2016.04.001. ISSN 0031-3955. PMC 4967225. PMID 27469176.
- Mercuri, Eugenio; Finkel, Richard S.; Muntoni, Francesco; Wirth, Brunhilde; Montes, Jacqueline; Main, Marion; Mazzone, Elena S.; Vitale, Michael; Snyder, Brian; Quijano-Roy, Susana; Bertini, Enrico; Davis, Rebecca Hurst; Meyer, Oscar H.; Simonds, Anita K.; Schroth, Mary K. (February 2018). "Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care". Neuromuscular Disorders. 28 (2): 103–115. doi:10.1016/j.nmd.2017.11.005. hdl:2434/702816. ISSN 1873-2364. PMID 29290580.
- "A Comprehensive Guide to Childhood Dementia: What You Need to Know". Discover Magazine. Retrieved 2024-09-24.